Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy

Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical oncology (Royal College of Radiologists (Great Britain)) 2025-01, Vol.37, p.103683, Article 103683
Hauptverfasser: Kamala, K., Sivaperumal, P.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 103683
container_title Clinical oncology (Royal College of Radiologists (Great Britain))
container_volume 37
creator Kamala, K.
Sivaperumal, P.
description
doi_str_mv 10.1016/j.clon.2024.103683
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3132141174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0936655524004795</els_id><sourcerecordid>3132141174</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1520-721fc04ffc18c794bdb0d59f41d0f4feb181de16ac42d17d1e79e81e00b62423</originalsourceid><addsrcrecordid>eNp9kM9q3DAQh0VJaTZpX6CHoGN68FYjyf9CLovZNIVAIPVdyNIoq8VrbyRvwM_VPsc-U202zbGngY_f_Jj5CPkKbAkMsu_bpWn7bskZlxMQWSE-kAVIIRJeFnBGFqwUWZKlaXpOLmLcMsZ4UZSfyLko0zznjC1IuB-b4C2tNn6HwRu66gb_jB19QoP7oQ_0ulo9faPH38c_tKYVtm2kbsKPQbe00p3BQOsNBr0fb-i628zE0l_a4TBS3Vla6_CMw8TWznmjzfiZfHS6jfjlbV6S-m5dV_fJw-OPn9XqITGQcpbkHJxh0jkDhclL2diG2bR0Eixz0mEDBViETBvJLeQWMC-xAGSsybjk4pJcn2r3oX85YBzUzkcz3a877A9RCRAcJEAupyg_RU3oYwzo1D74nQ6jAqZm1WqrZtVqVq1Oqqelq7f-Q7ND-77yz-0UuD0FcHry1WNQ0Xic9fiAZlC29__r_wvkPI-n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3132141174</pqid></control><display><type>article</type><title>Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy</title><source>Elsevier ScienceDirect Journals</source><creator>Kamala, K. ; Sivaperumal, P.</creator><creatorcontrib>Kamala, K. ; Sivaperumal, P.</creatorcontrib><identifier>ISSN: 0936-6555</identifier><identifier>ISSN: 1433-2981</identifier><identifier>EISSN: 1433-2981</identifier><identifier>DOI: 10.1016/j.clon.2024.103683</identifier><identifier>PMID: 39577200</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Clinical oncology (Royal College of Radiologists (Great Britain)), 2025-01, Vol.37, p.103683, Article 103683</ispartof><rights>2024 The Royal College of Radiologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1520-721fc04ffc18c794bdb0d59f41d0f4feb181de16ac42d17d1e79e81e00b62423</cites><orcidid>0000-0002-7032-1892</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0936655524004795$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39577200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamala, K.</creatorcontrib><creatorcontrib>Sivaperumal, P.</creatorcontrib><title>Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy</title><title>Clinical oncology (Royal College of Radiologists (Great Britain))</title><addtitle>Clin Oncol (R Coll Radiol)</addtitle><issn>0936-6555</issn><issn>1433-2981</issn><issn>1433-2981</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNp9kM9q3DAQh0VJaTZpX6CHoGN68FYjyf9CLovZNIVAIPVdyNIoq8VrbyRvwM_VPsc-U202zbGngY_f_Jj5CPkKbAkMsu_bpWn7bskZlxMQWSE-kAVIIRJeFnBGFqwUWZKlaXpOLmLcMsZ4UZSfyLko0zznjC1IuB-b4C2tNn6HwRu66gb_jB19QoP7oQ_0ulo9faPH38c_tKYVtm2kbsKPQbe00p3BQOsNBr0fb-i628zE0l_a4TBS3Vla6_CMw8TWznmjzfiZfHS6jfjlbV6S-m5dV_fJw-OPn9XqITGQcpbkHJxh0jkDhclL2diG2bR0Eixz0mEDBViETBvJLeQWMC-xAGSsybjk4pJcn2r3oX85YBzUzkcz3a877A9RCRAcJEAupyg_RU3oYwzo1D74nQ6jAqZm1WqrZtVqVq1Oqqelq7f-Q7ND-77yz-0UuD0FcHry1WNQ0Xic9fiAZlC29__r_wvkPI-n</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Kamala, K.</creator><creator>Sivaperumal, P.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7032-1892</orcidid></search><sort><creationdate>202501</creationdate><title>Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy</title><author>Kamala, K. ; Sivaperumal, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1520-721fc04ffc18c794bdb0d59f41d0f4feb181de16ac42d17d1e79e81e00b62423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamala, K.</creatorcontrib><creatorcontrib>Sivaperumal, P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical oncology (Royal College of Radiologists (Great Britain))</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamala, K.</au><au>Sivaperumal, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy</atitle><jtitle>Clinical oncology (Royal College of Radiologists (Great Britain))</jtitle><addtitle>Clin Oncol (R Coll Radiol)</addtitle><date>2025-01</date><risdate>2025</risdate><volume>37</volume><spage>103683</spage><pages>103683-</pages><artnum>103683</artnum><issn>0936-6555</issn><issn>1433-2981</issn><eissn>1433-2981</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39577200</pmid><doi>10.1016/j.clon.2024.103683</doi><orcidid>https://orcid.org/0000-0002-7032-1892</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0936-6555
ispartof Clinical oncology (Royal College of Radiologists (Great Britain)), 2025-01, Vol.37, p.103683, Article 103683
issn 0936-6555
1433-2981
1433-2981
language eng
recordid cdi_proquest_miscellaneous_3132141174
source Elsevier ScienceDirect Journals
title Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T22%3A01%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hybrid%20Chimeric%20Antigen%20Receptor%20(CAR)%20%CE%B3%CE%B4%20T%20Cells%20for%20Oral%20Cancer%20Therapy:%20Enhanced%20Safety%20and%20Targeted%20Efficacy&rft.jtitle=Clinical%20oncology%20(Royal%20College%20of%20Radiologists%20(Great%20Britain))&rft.au=Kamala,%20K.&rft.date=2025-01&rft.volume=37&rft.spage=103683&rft.pages=103683-&rft.artnum=103683&rft.issn=0936-6555&rft.eissn=1433-2981&rft_id=info:doi/10.1016/j.clon.2024.103683&rft_dat=%3Cproquest_cross%3E3132141174%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3132141174&rft_id=info:pmid/39577200&rft_els_id=S0936655524004795&rfr_iscdi=true